Eledon Pharmaceuticals, Inc. cotiza a 2.44 USD y tiene una capitalización bursátil de $198M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in devel…
| Métrica | ELDN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -56.3% | -40.4% | -15.9% |
| ROA | -27.0% | -32.0% | +5.0% |
| Current Ratio | 7.40 | 2.84 | +4.56 |
| Debt / Equity | — | 0.28 | — |